Taci Pereira is the Vice President and General Manager of Bioprinting at 3D Systems, where she leads the development and commercialization of 3D bioprinting technologies for tissue engineering research, drug discovery and development, and regenerative medicine. Prior to that, she was Chief Scientific Officer at Allevi, a global leader in 3D bioprinting, where she led the company’s scientific and business strategy, exiting to 3D Systems in May of 2021. Taci also leads the 3D bioprinting working group for the Regenerative Medicine Manufacturing Society, a professional society composed of key opinion leaders in the industry and academia dedicated toward advancing manufacturing solutions for the production of tissues, therapies and, ultimately, organs for regenerative medicine. Originally from Curitiba, Brazil, she has a B.Sc. in bioengineering from Harvard University, where she worked at the Wyss Institute for Biologically Inspired Engineering. Her research at the Mooney Laboratory for Cell and Tissue Engineering (Wyss) was focused on biomaterials for cancer immunotherapy, under the advisory of David Mooney (PhD).